{
    "id": 19761,
    "cites": 61,
    "cited_by": 15,
    "reference": [
        "Abadie, A., A. Diamond, and J. Hainmueller (2011): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093SYNTH: Stata module to implement Synthetic Control Methods for Comparative Case Studies,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Statistical Software Components.",
        "Abadie, A., and J. Gardeazabal (2003): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The economic costs of conflict: A case study of the Basque Country,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American economic review, pp. 113\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c132.",
        "Abadie, A. Diamond, A., and J. Hainmueller (2010): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Synthetic control methods for comparative case studies: Estimating the effect of Californias Tobacco Control Program, \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of the American Statistical Association, 105(490), 493\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c505.",
        "Acemoglu, D. (1998): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Why do new technologies complement skills? Directed technical change and wage inequality,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Quarterly Journal of Economics, 113(4), 1055\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1089.",
        "Acemoglu, D., and A. Finkelstein (2008): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Input and Technology Choices in Regulated Industries: Evidence from the Health Care Sector,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Political Economy, 116(5), 837\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c880.",
        "Acemoglu, D., and J. Linn (2004): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Quarterly Journal of Economics, 119(3), 1049\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 1090.",
        "Aghion, P., A. Dechezlepr\u00c3\u008b\u00e2\u0080\u00a0 etre, D. Hemous, R. Martin, and J. Van Reenen (2012): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Carbon taxes, path dependency and directed technical change: evidence from the auto industry,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Discussion paper, National Bureau of Economic Research.",
        "Arrow, K. (1962): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The economic implications of learning by doing,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The review of economic studies, 29(3), 155\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c173.",
        "(1963): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Uncertainty and the welfare economics of medical care,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The American economic review, 53(5), 941\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c973.",
        "Baicker, K., and A. Chandra (2011): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Aspirin, angioplasty, and proton beam therapy: the economics of smarter health care spending,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d in Prepared for Jackson Hole Economic Policy Symposium.",
        "Baicker, K., and D. Goldman (2011): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Patient Cost-Sharing and Health Care Spending Growth,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Economic Perspectives, 25(2), 47\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c68.",
        "Berndt, E. R., R. Glennerster, M. R. Kremer, J. Lee, R. Levine, G. Weizs acker, and H. Williams (2007): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Economics, 16(5), 491\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c511.",
        "Blume-Kohout, M., and N. Sood (2008): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Impact of Medicare Part D on Pharmaceutical R&D,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d NBER Working Papers 13857, National Bureau of Economic Research, Inc.",
        "Budish, E., B. N. Roin, and H. Williams (2013): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Do fixed patent terms distort innovation ? Evidence from cancer clinical trials,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d NBER Working Paper, (w19430).",
        "Chandra, A., and J. Skinner (2012): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Technology Growth and Expenditure Growth in Health Care,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Economic Literature.",
        "Chandra, A., and D. O. Staiger (2007): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Productivity Spillovers in Health Care: Evidence from the Treatment of Heart Attacks,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Political Economy, 115(1), 103\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 140.",
        "Chatterji, A., and K. Fabrizio (2011): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093How do product users influence corporate invention?,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Organization Science.",
        "Chatterji, A., K. Fabrizio, W. Mitchell, and K. Schulman (2008): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Physician-industry cooperation in the medical device industry,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Affairs, 27(6), 1532\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1543.",
        "Clemens, J., and J. Gottlieb (2013): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Bargaining in the Shadow of a Giant: Medicare\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Influence on Private Payment Systems,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d NBER Working Papers 19503, National Bureau of Economic Research, Inc. Clemens, J., and J. Gottlieb (Forthcoming): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Do Physicians Financial Incentives Affect Medical Treatment and Patient Health?,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Review.",
        "Cutler, D. (2004): Your money or your life: strong medicine for America\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s health care system. Oxford University Press, USA.",
        "Cutler, D., and M. McClellan (2001): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Is technological change in medicine worth it?,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health affairs, 20(5), 11\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c29.",
        "Cutler, D., A. Rosen, and S. Vijan (2006): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The value of medical spending in the United States, 1960\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2000,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d New England Journal of Medicine, 355(9), 920\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c927.",
        "Cutler, D. M., and D. P. Ly (2011): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The (Paper) Work of Medicine: Understanding International Medical Costs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Economic Perspectives, 25(2), 3\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c25.",
        "Damadian, R. (1974): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Apparatus and Method for Detecting Cancer in Tissue,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d US Patent 3,789,832.",
        "De Mouzon, O., P. Dubois, F. Scott Morton, and P. Seabright (2011): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Market Size and Pharmaceutical Innovation,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d CEPR Discussion Papers.",
        "Finkelstein, A. (2004): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Static and dynamic effects of health policy: Evidence from the vaccine industry,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Quarterly Journal of Economics, 119(2), 527\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c564.",
        "Finkelstein, A. (2007): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Quarterly Journal of Economics, 122(1), 1\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c37.",
        "Finkelstein, A., et al. (2012): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Oregon Health Insurance Experiment: Evidence from the First Year,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Quarterly Journal of Economics, 127(3), 1057\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1106.",
        "Freedman, S., H. Lin, and K. Simon (2012): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Public Health Insurance Expansions and Hospital Technology Adoption,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Discussion paper.",
        "Gailey, A., D. Lakdawalla, and N. Sood (2010): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Patents, innovation, and the welfare effects of Medicare Part D,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Advances in Health Economics and Health Services Research, 22, 317\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c344.",
        "Glennerster, R., M. Kremer, and H. Williams (2006): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Creating markets for vaccines,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d innovations, 1(1), 67\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c79.",
        "Hall, B., A. Jaffe, and M. Trajtenberg (2001): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The NBER patent citation data file: Lessons, insights and methodological tools,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Discussion paper, National Bureau of Economic Research.",
        "Hall, R. E., and C. . Jones (2007): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Value of Life and the Rise in Health Spending,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Quarterly Journal of Economics, 122(1), 39\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c72.",
        "Jaffe, A., M. Trajtenberg, and P. Romer (2005): Patents, citations, and innovations: A window on the knowledge economy. The MIT Press.",
        "Jones, C. . (2011): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Life and Growth,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d NBER Working Papers 17094, National Bureau of Economic Research, Inc.",
        "Kremer, M. (2002): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Pharmaceuticals and the developing world,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Journal of Economic Perspectives, 16(4), 67\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c90.",
        "Lakdawalla, D., and N. Sood (2009): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Innovation and the welfare effects of public drug insurance,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of public economics, 93(3), 541\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c548.",
        "Ledley, R. (1975): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Diagnostic X-Ray Systems,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d US Patent 3,922,552.",
        "Lettl, C., C. Herstatt, and H. Gemuenden (2006): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Users\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 contributions to radical innovation: evidence from four cases in the field of medical equipment technology,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d R&D Management, 36(3), 251\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c272.",
        "Malani, A., and T. Philipson (2011): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Discussion paper, National Bureau of Economic Research.",
        "Manning, W., et al. (1987): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Health insurance and the demand for medical care: evidence from a randomized experiment,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The American Economic Review, pp. 251\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c277.",
        "Moser, P. (2011): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Innovation Without Patents-Evidence from the Word Fairs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Working Paper.",
        "Moser, P., K. Bilir, and I. Talis (2011): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Do Treaties Encourage Technology Transfer? Evidence from the Paris Convention,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d .",
        "Moser, P., and A. Voena (2012): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Compulsory Licensing: Evidence from the Trading with the Enemy Act,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Review, 102(1), 396\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c427.",
        "Murphy, K. M., and R. H. Topel (2003): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The economic value of medical research,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Measuring the gains from medical research: An economic approach, 41.",
        "Newhouse, J. (1992): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Medical care costs: how much welfare loss?,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Journal of Economic Perspectives, 6(3), 3\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c21.",
        "Palmaz, J. (1988): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d US Patent 4,776,337.",
        "Petersen, M. A. (2009): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Estimating standard errors in finance panel data sets: Comparing approaches,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Review of financial studies, 22(1), 435\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c480.",
        "Popp, D. (2002): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Induced Innovation and Energy Prices,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American economic review, 92(1), 160\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c180.",
        "Popp, D., T. Juhl, and D. Johnson (2004): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Time in purgatory: Determinants of the grant lag for US patent applications,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Topics in Economic Analysis and Policy, 4(1), 1\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c43.",
        "Pozen, A., and D. Cutler (2010): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Medical Spending Differences in the United States and Canada: The Role of Prices, Procedures, and Administrative Expenses,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Inquiry: a journal of medical care organization, provision and financing, 47(2), 124.",
        "Roberts, E. (1988): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Technological innovation and medical devices,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d in New Medical Devices: Invention, Development, and Use, ed. by K. Ekelman, pp. 35\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c51. National Academy Press, Washington, DC.",
        "Shaw, B. (1985): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The role of the interaction between the user and the manufacturer in medical equipment innovation,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d R&D Management, 15(4), 283\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c292.",
        "(1986): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The role of the interaction between the manufacturer and the user in the technological innovation process,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Unpublished Ph. D. dissertation, University of Sussex.",
        "(1991): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Developing technological innovations within networks,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Entrepreneurship & Regional Development, 3(2), 111\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c128.",
        "Trajtenberg, M. (1989): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Welfare Analysis of Product Innovations, with an Application to Computed Tomography Scanners,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Political Economy, 97(2), pp. 444\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c479.",
        "Trajtenberg, M. (1990a): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A penny for your quotes: patent citations and the value of innovations,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Rand Journal of Economics, pp. 172\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c187.",
        "Trajtenberg, M. (1990b): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Product innovations, price indices and the (mis) measurement of economic performance,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Discussion paper, National Bureau of Economic Research.",
        "Von Hippel, E. (1976): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The dominant role of users in the scientific instrument innovation process,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Research policy, 5(3), 212\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c239.",
        "Wall, W. (1993): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Angioplasty stent,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d US Patent 5,192,307.",
        "Weisbrod, B. A. (1991): \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Health Care Quadrilemma: An Essay on Technological Change, Insurance, Quality of Care, and Cost Containment,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Economic Literature, 29, 523\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c552."
    ]
}